Features & Interviews

Features & Interviews

Debates, in-depth articles, and surprising profiles from ASH Clinical News

Order Matters: The Art and Science of Myeloma Drug Sequencing

Tuesday, March 28th, 2017
Examining the who, what, when, where, and why of myeloma treatment In 1844, Thomas Alexander Bean, one of the first documented patients with multiple myeloma...

Diversity Evolution

Wednesday, March 1st, 2017
The United States is becoming more diverse. Is the medical education system adapting quickly enough? The need for increased diversity in the medical profession is...

Pulling Back the Curtain: Michael Linenberger, MD

Wednesday, March 1st, 2017
What was your first job? I grew up in rural Kansas, so there were plenty of opportunities for employment – most of them were in...

Affordable Care Act: Exit, Stage Right

Thursday, February 2nd, 2017
The rollback of the Affordable Care Act (ACA) is underway. Within hours of taking the oath of office on January 20, President Donald Trump...

Cartwheels for CAR T-Cell Therapy?

Sunday, January 15th, 2017
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach to targeted immunotherapy to treat cancer, and the details can seem like the stuff...

Pulling Back the Curtain: Ross Levine, MD

Sunday, January 1st, 2017
What was your first job? My first summer jobs were at the publishing company where my mother was employed. I worked there for four summers...

Predatory Publishing: The Dark Side of the Open-Access Movement

Sunday, January 1st, 2017
In October 2016, we dived deep into the open-access (OA) movement – a publishing model in which a scientific article is made freely available...

Who’s In and Who’s Out?

Thursday, December 1st, 2016
Finding the balance in clinical trial eligibility between too strict, not strict enough, and “just right” To assess a drug or device’s safety and efficacy,...

To Test or Not to Test: Is Pharmacogenomic Testing for Warfarin Valuable?

Thursday, December 1st, 2016
Warfarin has been standard anticoagulation for more than 60 years, but the significant variability in both warfarin pharmacokinetics and pharmacodynamics makes achieving therapeutic drug...

A Way With Words: David Steensma, MD

Thursday, December 1st, 2016
When did your interest in crossword puzzles start? Did you enjoy puzzles growing up? My mother has long been an avid “cruciverbalist” – a crossword...
Advertisement

Current Issue

April 2017, Volume 3, Issue 5

This issue examines the art and science of myeloma drug sequencing, Mikkael Sekeres' letter to the ABIM, highlights from the 16th International Myeloma Workshop, and more.